SENSEX NIFTY

Us Manufacturing Ism

Mar 04, 2015 at 12:00 | Source: Moneycontrol.com
Sun Pharma topped the buying list on Sensex, up 6 percent. Even its subsidiary Sun Pharma Advanced Research Company gained 6 percent on getting US FDA nod for Elepsia XR extended release tablets, an anti-epileptic drug. SPARC says product will be manufactured by Sun Pharma at Halol unit.
Feb 23, 2015 at 15:17 | Source: Reuters
The FDA inspected the plant in January this year, after which it issued the company a so-called Form 483, listing six observations on the manufacturing processes at the plant, Lupin said in a statement, without giving details.
Feb 23, 2015 at 11:08 | Source: Moneycontrol.com
According to Angel Broking, Indian Rupee is expected likely to depreciate today owing to strength in the DX following robust manufacturing data from the US. Also, month-end dollar demand from importers will keep the rupee under pressure and will act as a negative factor.
Feb 18, 2015 at 14:40 | Source: Moneycontrol.com
Cheap imports from China and other South East Asian countries have added to the woes of Indian manufacturers. According to government figures, imports from China into India have increased from US$30.8 billion in 20092010 to US$51.0 billion in 201314 , growing at a CAGR of 13.4%.
Feb 13, 2015 at 12:48 | Source: Reuters
The company also said it is close to securing a manufacturing partner in Brazil, which will help it skirt punishing tariffs on imported electronics when it begins sales in Latin America's largest economy in the first half of this year.
Feb 12, 2015 at 15:46 | Source: CNBC-TV18
Intimating mediapersona about the dialogue between the two nations, Jaitley said the discussions veered around ease of doing business in India, scope of investment in infra and manufacturing, terror funding, money laundering cooperation to check black money etc.
Jan 28, 2015 at 08:17 | Source: CNBC
The consumer-technology supplier beat on both the top and bottom lines in releasing results after Tuesday's close, with its shares rising in extended-hours trading.
Jan 27, 2015 at 13:17 | Source: PTI
Drug major Ranbaxy today said that the US health regulator has "determined" that the Indian drug manufacturer has forfeited its 180 days exclusivity for stomach and esophagus problems treatment tablets.
Jan 25, 2015 at 14:43 | Source: CNBC-TV18
India would require USD 3 trillion in activities like infrastructure, defence, services, manufacturing, says Ashish Chauhan, CEO BSE.
Jan 23, 2015 at 08:30 | Source: PTI
On US President Barack Obama's visit to India, Jaitley said he expects very positive outcome and the relationship between the two countries has matured considerably.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.